semaglutide stalled weight loss I compare two medications with my patients every single week. Here's what the data actually shows. (Ozempic/Wegovy) delivered a 13.7% average weight loss in clinical trials. That's significant. But Semaglutide: A Weight Loss Breakthrough

Data from the World Health Organization (WHO) shows that obesity has almost tripled globally since 1975, impacting over 650 million adults and 340 million children and adolescents in 2016

The research: Developed by Monash University in Australia

As with all medications, GLP-1 receptor agonists carry potential adverse effects, most commonly gastrointestinal symptoms such as nausea, vomiting, diarrhoea, and constipation

Edited by Professor Alessandro Finazzi-Agr Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made

If its clinically appropriate and safe, your provider can create a personalized treatment plan and may prescribe Wegovy, a brand name for semaglutide approved for weight loss